Health Coaching-Based Navigation at the Conclusion of Treatment for the Support of Black Breast Cancer Survivors

PRIMARY OBJECTIVE:

I. To evaluate the feasibility of coaching-based navigation for black breast cancer survivors including recruitment, dropout, and survey completion rates.

SECONDARY OBJECTIVES:

I. To evaluate the preliminary impact of health coaching on completion of scheduled survivorship related referrals and participation in support services.

II. To determine the preliminary impact on quality of life and self-efficacy pre and post coaching.

OUTLINE:

Patients are assigned a Black patient navigator for racial concordance and receive coaching from patient navigator over 30 minutes every other week for 3 months and then monthly for 3 months.

• Patient Navigation (Behavioral), also known as Patient Navigator Program: Assigned a patient navigator and receive coaching
• Quality-of-Life Assessment (Other), also known as Quality of Life Assessment: Ancillary studies
• Questionnaire Administration (Other): Ancillary studies

Primary outcomes

• Recruitment rate [Up to 6 months]: Will be calculated as the number of new eligible women per month.
• Consent rate [Up to 6 months]: Will be calculated as the number of consented women (set to 40 for this study) divided by the total number of women approached.
• Dropout rate [Up to 6 months]: Will be calculated as the percentage of women who are enrolled in the study but withdraw before the conclusion of the study.
• Patient-Reported Outcomes Measurement Information System score [Up to 6 months]: Differences in scoring at the start of the study period and at the end of the trial will also be summarized by mean, standard deviation, and range.
• European Organization for Research and Treatment of Cancer Quality of Life-30 score [Up to 6 months]: Differences in scoring at the start of the study period and at the end of the trial will also be summarized by mean, standard deviation, and range.
• Breast Cancer Self Efficacy Scale score [Up to 6 months]: A self reported, unidimensional, 11 item scale designed to show the differences in scoring at the start of the study period and at the end of the trial will also be summarized by mean, standard deviation, and range.

Sex: Female, ages: 18 Years to any

Inclusion Criteria:

* Black women > 18 years of age with stage I-III primary breast cancer who have completed definitive breast cancer treatment

• Informed Consent Form (PDF, 2021-07-29)

• Bridget A Oppong, MD, Principal investigator, Ohio State University Comprehensive Cancer Center